Photo: CDC | Unsplash
According to the Indian Council of Medical Research, colon cancer is the third most common form of cancer in men and the second most common in women. It's also notorious as one of the forms of cancer that's detected at really late stages. A new study, led by Dr. Sagar Sengupta from the National Institute of Immunology, has found a novel way to identify the disease as early as stage 1 through his lab's work on microRNAs. We believe that the identified DNA damage sensitive microRNAs (DDSM) can serve as an invaluable biomarker for colon cancer early detection process. We now have to determine whether the DDSM's can also be detected as simple as the detection of blood sugar in diabetic patients, said Dr. Sengupta.
|
|
More:
